Language selection

Search

Patent 2275377 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 2275377
(54) English Title: ENCAPSULATION
(54) French Title: ENCAPSULATION
Status: Deemed Abandoned and Beyond the Period of Reinstatement - Pending Response to Notice of Disregarded Communication
Bibliographic Data
(51) International Patent Classification (IPC):
  • B01J 13/02 (2006.01)
(72) Inventors :
  • QUINN, DENNIS WILLIAM (United Kingdom)
  • THOMPSTONE, ALEXANDER MARTIN (United Kingdom)
(73) Owners :
  • CHEMCOLLOIDS LIMITED
(71) Applicants :
  • CHEMCOLLOIDS LIMITED (United Kingdom)
(74) Agent: OSLER, HOSKIN & HARCOURT LLP
(74) Associate agent:
(45) Issued:
(86) PCT Filing Date: 1997-12-16
(87) Open to Public Inspection: 1998-06-25
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/GB1997/003346
(87) International Publication Number: GB1997003346
(85) National Entry: 1999-06-16

(30) Application Priority Data:
Application No. Country/Territory Date
9626152.4 (United Kingdom) 1996-12-17

Abstracts

English Abstract


A colloidal aggregate suitable for use in the curing of resins comprises a
continuous phase of a water based encapsulent material and a dispersed phase
comprising one or more strong acids. The continuous phase advantageously
comprises a mixture of gelatin and xanthan gum. The aggregate is sonicated to
encapsulate the acid in the encapsulent material. The encapsulated acid is
mixed with a curable resin. The acid capsules may be ruptured by any suitable
means, but particularly ultrasound, to release the acid to initiate curing of
the resin.


French Abstract

La présente invention concerne un agrégat colloïdal utilisé pour le traitement de résines, comprenant une phase continue d'un matériau agent d'encapsulation à base d'eau et une phase dispersée comprenant un ou plusieurs acides forts. La phase continue comprend avantageusement un mélange de gélatine et de gomme xanthane. L'agrégat est soumis à un traitement ultrasonique de manière à encapsuler l'acide dans le matériau agent d'encapsulation. L'acide encapsulé est mélangé avec une résine polymérisable. Les capsules d'acide peuvent être rompues par tout moyen approprié mais plus particulièrement par des ultrasons, de manière à libérer l'acide pour amorcer le traitement de la résine.

Claims

Note: Claims are shown in the official language in which they were submitted.


-14-
CLAIMS
1. A microcapsule suitable for use in the curing of resins
comprising a membrane of a water based encapsulation material and
an encapsulated phase comprising one or more strong acids wherein
the membrane may be ruptured by an external energy source to
release the acid.
2. A microcapsule as claimed in claim 1, in which the encapsulent
comprises a water based acid resistant gelatin.
3. A microcapsule as claimed in claim 1 or 2, in which the
encapsulent comprises a mixture of gelatin and xanthan gum.
4. A microcapsule as claimed in claim 1 or 2, in which the
encapsulent comprises a mixture of gelatin and gellan gum.
5. A microcapsule as claimed in claim 1 or 2, in which the
encapsulent comprises a mixture of gum arabic and xanthan gum.
6. A microcapsule as claimed in claim 1 or 2, in which the
encapsulent comprises a mixture of gelatin and tragacanth.
7. A microcapsule as claimed in claim 1 or 2, in which the
encapsulent comprises a mixture of gum arabic and tragacanth
8. A microcapsule as claimed in claim 1 or 2, in which the
encapsulent comprises a mixture of gelatin and gum arabic
9. A microcapsule as claimed in claim 1 or 2, in which the

-15-
encapsulent comprises a mixture of gelatin and polyglycol alginates.
10. A microcapsule as claimed in claim 1 or 2, in which the
encapsulent comprises a mixture of gum arabic and gellan gum.
11. A microcapsule as claimed in any of claims 3 to 10 in which
the ratio of the two ingredients to each other lie in the ranges 99.9
to 49.9 and 0.1 to 50.1.
12. A microcapsule as claimed in claim 1, in which the encapsulent
comprises hydrolysed gelatin, alginates; carrageenan (Kappa, Iota and
Lambda), locust bean gum, gum arabic, high methoxyl pectins, gellan
gum, methyl cellulose and methyl hydroxpropyl cellulose or any
combination thereof or agar.
73. A microcapsule as claimed in claim 1, in which the encapsulent
comprises xanthan gum combined with one of the following
hydroxyethyl cellulose, carboxymethyl cellulose, gum arabic,
tragacanth, gellan gum, sulphuric acid monoesters of gum
tragacanth, polyglycol alginates, low methoxyl pectins.
14. A microcapsule as claimed in claim 1 or 2, in which the strong
acid comprises sulphuric acid, or hydrochloric acid, or phosphoric
acid, or toluene sulphonic acid or a mixture thereof.
15. A resin system for the production of rigid articles wherein said
resin systems comprises resin and a dispersed catalyst/initiator said

-16-
catalyst/initiator being microcapsule comprising a membrane of a
water based encapsulent material and a dispersed phase comprising
one or more strong acids wherein the membrane may be ruptured by
an external energy source to release the acid into the resin and
thereby initiating/catalysing the resin curing.
16. A fibrous carrier layer impregnated with a resin system as
claimed in claim 15.
17. A fibrous carrier layer as claimed in claim 16 which is shaped
while uncured.
18. A fibrous carrier layer as claimed in claim 16 or 17 which has
a fibrous sheet structure including a mat, a web or randomly
orientated fibres.
19. A fibrous carrier layer as claimed in claim 18, in which the
fibres are of glass.
20. A method for the microencapsulation of one or more strong
acids suitable for use as catalysts, promoters or initiators in resin
curing reactions, comprising the following steps:
mixing the acid(s), a water based encapsulent and water,
sonicating the mixture so formed to encapsulate the acid(s) in
the encapsulent, and
substantially removing surplus water from the mixture to form

-17-
a microcapsule of the acid in the encapsulent.
21. A method as claimed in claim 20 in which the mixture is
sonicated with ultrasound.
22. A method as claimed in claim 21, in which the mixture is
sonicated with audible sound.
23. A method as claimed in claims 20, 21 or 22, in which the
capsules formed in the sonification step are heated for a period of
about twenty four hours at a temperature below 80°C.
24. A method as claimed in claim 23 in which the capsules are
heated at a temperature between 60° and 70°C.

Description

Note: Descriptions are shown in the official language in which they were submitted.


CA 02275377 1999-06-16
-1-
~NCAP~,ILATION
The present invention relates to microcapsules of acid and to
a method of their production. The invention is particularly, but not
exclusively concerned with microcapsules of catalysts and/or
initiators used in the curing of synthetic resins.
In the majority of uses, the processing and curing of resins is
carried out under controlled conditions. However, circumstances
occur when it is necessary to control/prevent the curing of a resin
before an appropriate time in order to attain the best utilisation of the
resin.
The majority of thermoset resin applications use heat to cure
the resin, the application of heat causing a catalyst and7or p~oimoter
in the resin to accelerate the cross-linking of resin molecules.
1 ~ However; even if heat is not applied, the resin will cure over a period
of days, thereby restricting the time during which uncured resin can
be stored. Therefore, from the above it can be seen that as soon as
the resin is mixed with its catalyst and is used for the specific
application there is a race against time to get the resin/catalyst
system in place.
The industry is aware of this problem and some attempts have
AMENDED SHEET

CA 02275377 1999-06-16
PCTIGB971Q3346
WO 98126865
-2
been made to solve 'rt by developing special resins which are curable
by light radiation.
Ultra small microcapsules of the order of less than 100 micron
diameter, are formed which are of appropriate size to be used in
thermoset applications when such microcapsules are dispersed
throughout the resin. When the microcapsules are so small they can
be uniformly dispersed and will not settle out in the resin.
One particular class of resin is that of phenolic resins which are
the products of reactions between phenols (commonly phenol) and
aldehydes (typically formaldehyde). One of the main advantages of
using phenolic resin systems for the thermoset resin industry is that
the resin initially comprises a low molecular weight fusible solid resin
that may be easily handled and subsequently, upon curing, forms a
high molecular weight, strong, heat resistant material.
Phenolic resins are usually initiated/catalysed by the addition
of strong acids such as sulphuric acid, hydrochloric acid, phosphoric
acid, Toluenesulphonic acid and the like, all of which are extremely
corrosive and difficult to handle. The corrosive nature of the acids is
one of the main factors which have made them exceptionally difficult
to encapsulate and without some form of encapsulation or controlled
release it is impossible to control the release of the acid into the

CA 02275377 1999-06-16
-3-
resin. Another class of resins is urea formaldehyde is also of interest.
An object of this invention is to provide capsules of strong
acids which are readily dispersable in resin material without acid
leakage.
Furthermore, the present invention also seeks to provide
curable resin systems for the production of rigid articles wherein the
resin can be cured readily and quickly, but retains a long shelf life
making it particularly suitable for use in the thermoset resin industry.
According to one aspect of the present invention there is
provided a microcapsule suitable for use in the curing of resins
comprising a membrane of a water based encapsulation material and
an encapsulated phase comprising one or more strong acids wherein
the membrane may be ruptured by an external energy source to
release the acid.
Preferably the encapsulent comprises a water based acid
resistant gelatin.
The strong acid may comprise sulphuric acid, hydrochloric
acid, phosphoric acid and toluene sulphonic acid or a mixture thereof.
According to another aspect of the invention there is provided
a resin system for the production of rigid articles wherein said resin .
systems comprises resin and a dispersed catalyst/initiator said

CA 02275377 1999-06-16
catalystlinitiator being microcapsute comprising a membrane of a
water based encapsulent material and a dispersed phase comprising
one or more strong acids wherein the membrane may be ruptured by
an external energy source to release the acid into the resin and
thereby initiatinglcatalysing the resin curing.
One advantage of this type of encapsulation over the prior art
is the fact that previously the encapsulated reactant was produced
in the form of dry capsules which were often poorly dispersed when
mixed in with resin, whereas the materials of the present invention
are readily dispersed ensuring intimate dispersion in the resin and
significantly reducing the likelihood of the presence of large
conglomerates of capsules.
The invention has a general application in that a resin
impregnated absorbent material with the dispersed colloidal capsules
therein can be shaped to a final form and the colloidal capsules
ruptured, for example by heating or electromagnetic energy, to
release the catalyst or promotes, to cause curing of the resin and
absorbent material in said final form.
In one embodiment of the present invention the encapsulated
ZO catalyst is admixed with the curable resinous material which is then
used to impregnate a fibrous carrier layer.

CA 02275377 1999-06-16
-5-
The fibrous layer can be shaped to any desired shape, such as
a boat or moulded part for a vehicle whilst the resin is uncured, and
then the resin can be cured for example by the application heat or
electromagnetic energy to rupture the colloidal capsules.
The resinlcolloidal capsule carrier material preferably has a
fibrous sheet structure including a mat, a web or randomly orientated
fibres and the fibres may be of glass and/or of natural and synthetic
origin.
According to a still further aspect of the present invention
there is also provided a method for the microencapsulation of one or
more strong acids suitable for use as catalysts, prorr~oters or initiators
in resin curing reactions, comprising the following steps:-
mixing the acid(s), a water based encapsulent and water,
sonicating the mixture so formed to encapsulate the acids) in
IS the encapsulent, and
substantially removing surplus water from the mixture to form
a microcapsule of the acid in the encapsulent.
By way of a specific example when acid resistant gelatin is
used application of ultrasonic energy or gelatin in the sonicating step
causes free-radical induced cross-linking of protein molecules. Highly
reactive radicals in particular H~ and OH~ are ultrasonically produced

CA 02275377 1999-06-16
-6-
from water and react with molecular oxygen present in the
solution/air to form a superoxide HOZ,). Superoxide reacts with
protein molecules to produce disulphuric bonding usually between
cysteine residues. Ultrasound can produce a high concentration of
proteinaceous colloidal capsules with narrow size distributions,
generally in region of 9-20 microns.
A typical ultrasonic reactor apparatus for use in the
preparations of this invention comprises a collimated 20 Khz beam
from a lead zirctinate ~ titanate transducer and the reaction may be
carried out in a glass sonication cell in an inert atmosphere,
preferably in an atmosphere of argon. An amplifying horn; preferably
made of titanium may be fixed adjacent to .the transducer, for.
amplification of the signal thereof_ Because of temperature rises due
to 'the reaction processes 'the sonication cell is preferably retained in
a water bath. Audible sound may also be used.
Preferably in the water removal step, the aqueous mixture of
the capsules formed in the sonification step are heated .for. a period
of about 24 hours at a temperature below the rupture temperature of
around 80°C and is preferably heated between 60 and 70°C.
The present invention will be better understood by way of the
following examples which describe the encapsulation of strong acids

CA 02275377 1999-06-16
in water based encapsulents for use as catalystslinitiators for
polymerisation reactions.
Example 1
The curing of phenolic resin is generally initiatedlcatalysed by
the addition of strong acids and the reaction proceeds at ambient
temperature.
In this example the curing agent which was encapsulated was
a propriety blend of phosphoric and toluene sulphonic acids.
One part by weight of the acid mixture was mixed with 3 parts w
by weight of food grade gelatin (200 Bloom) dispersed in 3 parts of
water.
This mixture was sonicated for a period of three minutes
(power 100V11) using a 20 Khz probe: The high intensity ultrasound, ~,
produced intermediate proteinaceous capsules in a substantially-
i 5 aqueous 'medium and were of a sizes' less than 100 advantageously
microns wherein capsules are dispersed in water and comprise an
outer layer of gelatin encapsulating a strong acid core.
It was found however that because acid mixture contained
strong acids, a gel/water boundary developed around the acid
catalyst leading to diffusion of the acid through the shell. !t would
seem that is because the water present in and around each capsule

CA 02275377 1999-06-16
_$_
shell acts as a carrier for the acid.
tt was subsequently found that an improved encapsulated
product was prepared by eliminating water from the aqueous mixture
to prevent the acids traversing the cell wall. The sonicated mixture
was therefore heated in an oven at 70'C until the three parts water
had been removed to form the end product material.
Example 2
In a further experiment 10% by weight of acid mixture was
mixed with 10% of acid resistant gelatin (Gelatex, Che~n. Colloids
Ltd) and 10% water and the mixture was sonicated for 3 minutes
using 20KHz probe (70 Watts) producing proteinaceous colloidal
capsules with particle sizes of less than 100 microns advantageously
between 1 and 20 microns.
The gelatin/water/acid colloid was heated in an oven at 60'C
for 24 hours to remove the water from the gelatin/water boundary
leaving a gelatin capsule.
It has been found that gelatin capsules of the present invention
of acid mixture have a shelf life of at least 3 months and that upon
heating samples thereof up to 90'C in the presence of phenolic resins
a cure is obtained within 5 minutes.
The encapsulation material may take many different forms.

CA 02275377 1999-06-16
WO 98126865 PCTIGB97/03346
-9-
For example, a material comprising a combination of gelatin
with xanthan gum has been found to be particularly advantageous
combining longtime resistance to acid attack with ready
encapsulation of acid and rupturing of the encapsulation on
application of an external energy source such as ultrasound.
Preferred formulations of the above ingredients lie in
the
following range:-
Xanthan Gum 0.1 - 50.1
Gelatin 99.9 - 49.9
The material is produced by the adhesion, agglomeration
and
enrobing of gelatin with xanthan gum. Apart from the above
ingredient combinations, the following ingredients in the
following
ingredient combinations may also be used:-
(a) Gelatin 99.9 - 49.9
Gellan Gum 0.1 - 50.1
(b) Gum Arabic 99.9 - 49.9
Xanthan Gum 0.1 - 50.1
(c) Gum Arabic 99.9 - 49.9
Gellan Gum 0.1 - 50.1
(d/ Gellatin 99.9 - 49.9
Tragacanth 0.1 - 50.1
(e) Gum Arabic 99.9 - 49.9
Tragacanth 0.1 - 50.1

CA 02275377 1999-06-16
WO 98/26865 PCTIGB97/03346
-10-
(f) Gelatin 99.9 - 49.9
Gum Arabic 0.1 - 50.1
(g) Gelatin 99.9 - 49.9
Polyglycol Alginates 0.1 - 50.1
A blend of all the above combinations may also be employed.
In any combination comprising gelatin any of the following may
be employed as alternatives:
- Hydrolysed Gelatin
- Alginates
Carrageenan (Kappa, Iota and Lambda)
- Locust Bean Gum
- Gum Arabic
- High Methoxyl Pectins
- Gellan Gum
- Methyl Cellulose and Methyl Hydroxpropyl Cellulose
or any mixture/modifications of the above
- Agar
In any combination comprising xanthan gum any of the
foNowing may be employed as alternatives:-
- Hydroxyethyl Cellulose '
- Carboxymethyl Cellulose
- Gum Arabic

CA 02275377 1999-06-16
WO 98126865 PCT/GB97103346
-11-
- Tragacanth
- Gelian Gum
- Sulphuric Acid Monoesters of Gum Tragacanth
- Polyglycol Alginates
- Low Methoxyl Pectins
In the above, the following terms have the following
meanings:-
(a) Gelatin and Hl~rdrolysed Gelatin
Protein derived from the hydrolysis of animal collagen
i0 (including ash) or any short chain combination of
constituent amino acids.
(b) Carrageenan and Agar
Products extracted from red seaweed having galatose
backbone joined together by alternating glycosidic
15 linkages.
(c) Guar. Locust Bean Tara Cassia Mesauite and
Fenugreek gum
Galactomannans - a family of linear polysaccharides
based on a backbone of ~i(1-4)-linked D-mannose
20 residues.
(d) Gum Arabic Gum Tragiacanth and Gum Ka~yra

CA 02275377 1999-06-16
WO 98J26865 PCT/GB97/03346
-12-
Exudate Gums - yielded from species of trees and
shrubs, which first appears as a liquid and is dried in the
sun and air to form a hard glassy lump.
(e) Xanthan and Gellan Gum
Biosynthetic Polysaccharide Gums - produced by
fermentation using specific bacteria.
(f) Alginates and Alginate Esters
Salts of Alginic Acid - with a degree of polymerisation
usually in the range of 700 - 3000 corresponding to
molecular weights of approximately 20,000 - 600,000.
Propylene Glycol Alginate (PGA) is an ester of alginic
acid and propylene glycol.
(g) Methyrl Cellulose. Methyl Hydroxl~ro~yl Cellulose
Hvdroxvethyrl Cellulos and Carboxyrmet yl Cellulose
Cellulose Ethers - prepared by reacting cellulose with
caustic to form 'alkali cellulose' which in turn is
alkylated or alkoxylated in the presence or absence of
inert diiuent or by Williamson Etherification reaction.
(h) Low Methoxyrl Pectins and High Methoxyl Pectins
Pectins - are the partial breakdown products of complex

CA 02275377 1999-06-16
-13-
structures in plant cell wall (normally fruits). These can .
be modified by de-esterification to produce high
methoxyl and low methoxy! pectins.
The capsules of acid may be mixed with the resin to be cured
by any suitable means. The resins may be phenolic or urea
formaldehyde. The very small size of the capsules facilitates dispersal
in the resin. The mixing process is low energy, low shear to avoid
premature rupturing of the capsules. A suitable form of mixer may
be a paddle mixer. The shelf life of a product comprising resin to be
cured and encapsulated acid may be tailored to a customer's
requirements_ Shelf lives of at least three months and possibly of
longer than one year may be achieved. -
The capsules dispersed in the resin may be ruptured ~to release
the acid to initiate curing by any suitable means: Appropriate means
1:. include heating, sound, ultrasound; radio waves, microwaves or
pressure_ The latter may be particularly advantageous in the
production of products which inherently involve the application of
pressure such as for example laminated products.

Representative Drawing

Sorry, the representative drawing for patent document number 2275377 was not found.

Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: Agents merged 2013-10-24
Application Not Reinstated by Deadline 2002-12-16
Time Limit for Reversal Expired 2002-12-16
Deemed Abandoned - Failure to Respond to Maintenance Fee Notice 2001-12-17
Letter Sent 2000-07-12
Letter Sent 2000-07-12
Inactive: Single transfer 2000-06-01
Inactive: Cover page published 1999-09-13
Inactive: First IPC assigned 1999-08-16
Inactive: Courtesy letter - Evidence 1999-08-03
Inactive: Notice - National entry - No RFE 1999-07-28
Application Received - PCT 1999-07-26
Amendment Received - Voluntary Amendment 1999-06-17
Application Published (Open to Public Inspection) 1998-06-25

Abandonment History

Abandonment Date Reason Reinstatement Date
2001-12-17

Maintenance Fee

The last payment was received on 2000-12-14

Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following

  • the reinstatement fee;
  • the late payment fee; or
  • additional fee to reverse deemed expiry.

Patent fees are adjusted on the 1st of January every year. The amounts above are the current amounts if received by December 31 of the current year.
Please refer to the CIPO Patent Fees web page to see all current fee amounts.

Fee History

Fee Type Anniversary Year Due Date Paid Date
Basic national fee - standard 1999-06-16
MF (application, 2nd anniv.) - standard 02 1999-12-16 1999-11-29
Registration of a document 2000-06-01
MF (application, 3rd anniv.) - standard 03 2000-12-18 2000-12-14
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
CHEMCOLLOIDS LIMITED
Past Owners on Record
ALEXANDER MARTIN THOMPSTONE
DENNIS WILLIAM QUINN
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Abstract 1999-06-15 1 48
Description 1999-06-15 13 353
Claims 1999-06-15 4 98
Reminder of maintenance fee due 1999-08-17 1 114
Notice of National Entry 1999-07-27 1 208
Request for evidence or missing transfer 2000-06-18 1 110
Courtesy - Certificate of registration (related document(s)) 2000-07-11 1 115
Courtesy - Certificate of registration (related document(s)) 2000-07-11 1 115
Courtesy - Abandonment Letter (Maintenance Fee) 2002-01-13 1 182
Reminder - Request for Examination 2002-08-18 1 116
PCT 1999-06-15 20 625
Correspondence 1999-08-02 1 30
PCT 1999-06-16 4 137
Fees 2000-12-13 1 53
Fees 1999-11-28 1 57